Neoadjuvant Chemotherapy and Targeted Therapies: a Promising Strategy

Author： Metzger-Filho Otto   de Azambuja Evandro  

Publisher： Oxford University Press

ISSN： 1052-6773

Source： Journal of the National Cancer Institute Monographs, Vol.2011, Iss.43, 2011-10, pp. : 116-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neoadjuvant chemotherapy for bladder cancer

By Millikan R.   Siefker-Radtke A.   Grossman H.B.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 464-467

Elsevier

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy in Bladder Cancer

By Vaughn David J.  

American Journal of Cancer, Vol. 4, Iss. 2, 2005-01 ,pp. : 71-75

Adis International

Access to resources Recommend Favorite

Association of BMI with overall survival in patients with mCRC who received chemotherapy versus EGFR and VEGF‐targeted therapies

By  

Cancer Medicine, Vol. 2045-7634, Iss. 10, 2015-10 ,pp. : 1461-1471

John Wiley & Sons Inc

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer

By Irmscher Sabrina  

Annals of Surgical Oncology, Vol. 15, Iss. 7, 2008-07 ,pp. : 2059-2060

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy for Advanced Ovarian Cancer

By Eisenkop S.M.   Spirtos N.M.   Friedman R.L.  

Gynecologic Oncology, Vol. 74, Iss. 2, 1999-08 ,pp. : 311-312

Elsevier

Access to resources Recommend Favorite